[Cellular replacement strategies and adult neurogenesis in idiopathic Parkinson's disease]
- PMID: 27389601
- DOI: 10.1007/s00115-016-0157-2
[Cellular replacement strategies and adult neurogenesis in idiopathic Parkinson's disease]
Abstract
Parkinson's disease (PD) is the most common age-related movement disorder and characterized by slowly progressive neurodegeneration resulting in motor symptoms, such as bradykinesia, rigidity, tremor and postural instability. Moreover, non-motor symptoms, such as hyposmia, anxiety and depression reduce the quality of life in PD. Motor symptoms are associated with a distinct striatal dopaminergic deficit resulting from axonal dysfunction and neuronal loss in the substantia nigra (SN). Recent progress in stem cell technology allows the optimization of cellular transplantation strategies in order to alleviate the motor deficit, which potentially leads to a reactivation of this therapeutic strategy. Besides neurodegenerative processes impaired adult neurogenesis and consequentially reduced endogenous cellular plasticity may play an important role in PD. This article discusses the notion that non-motor symptoms in PD may partly be explained by reduced adult neurogenesis in the olfactory bulb and hippocampus.
Keywords: Hippocampus; Neural stem cells; Neurodegeneration; Olfactory bulb; Transplantation.
Similar articles
-
Adult neurogenesis in Parkinson's disease.Cell Mol Life Sci. 2013 Feb;70(3):459-73. doi: 10.1007/s00018-012-1062-x. Epub 2012 Jul 6. Cell Mol Life Sci. 2013. PMID: 22766974 Free PMC article. Review.
-
Restoration of Adult Neurogenesis by Intranasal Administration of Gangliosides GD3 and GM1 in The Olfactory Bulb of A53T Alpha-Synuclein-Expressing Parkinson's-Disease Model Mice.Mol Neurobiol. 2023 Jun;60(6):3329-3344. doi: 10.1007/s12035-023-03282-2. Epub 2023 Feb 28. Mol Neurobiol. 2023. PMID: 36849668 Free PMC article.
-
Abnormal hippocampal neurogenesis in Parkinson's disease: relevance to a new therapeutic target for depression with Parkinson's disease.Arch Pharm Res. 2018 Oct;41(10):943-954. doi: 10.1007/s12272-018-1063-x. Epub 2018 Aug 22. Arch Pharm Res. 2018. PMID: 30136247 Review.
-
Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment.Arch Pharm Res. 2021 Jun;44(6):588-604. doi: 10.1007/s12272-021-01337-3. Epub 2021 Jun 19. Arch Pharm Res. 2021. PMID: 34145553 Free PMC article. Review.
-
Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.CNS Neurol Disord Drug Targets. 2012 Nov 1;11(7):907-20. doi: 10.2174/1871527311201070907. CNS Neurol Disord Drug Targets. 2012. PMID: 23131153 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical